These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 3702600

  • 1. The effect of thioridazine on haloperidol induced behavioral hypersensitivity.
    Klawans HL, Carvey PM, Nelson D, Tanner CM, Goetz CG.
    Life Sci; 1986 May 12; 38(19):1707-14. PubMed ID: 3702600
    [Abstract] [Full Text] [Related]

  • 2. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J, Devanand DP, Carey RJ.
    Biol Psychiatry; 1982 Nov 12; 17(11):1289-301. PubMed ID: 6891268
    [Abstract] [Full Text] [Related]

  • 3. Clozapine fails to prevent the development of haloperidol-induced behavioral hypersensitivity in a cotreatment paradigm.
    Carvey PM, Nath ST, Kao LC, Zhang TJ, Lin DH, Singh R, Amdur RL, Klawans HL.
    Eur J Pharmacol; 1990 Aug 02; 184(1):43-53. PubMed ID: 2209714
    [Abstract] [Full Text] [Related]

  • 4. Neuroleptic-induced dopamine hyposensitivity.
    Goetz CG, Carvey PM, Tanner CM, Klawans HL.
    Life Sci; 1984 Apr 09; 34(15):1475-9. PubMed ID: 6538629
    [Abstract] [Full Text] [Related]

  • 5. Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine.
    Smith RC, Davis JM.
    Life Sci; 1976 Sep 01; 19(5):725-31. PubMed ID: 986527
    [No Abstract] [Full Text] [Related]

  • 6. The pathophysiology of tardive dyskinesia.
    Klawans HL, Carvey P, Tanner CM, Goetz CG.
    J Clin Psychiatry; 1985 Apr 01; 46(4 Pt 2):38-41. PubMed ID: 2858479
    [Abstract] [Full Text] [Related]

  • 7. Detection of the nueroleptic properties of clozapine, sulpiride and thioridazine.
    Costall B, Naylor RJ.
    Psychopharmacologia; 1975 Jul 23; 43(1):69-74. PubMed ID: 1172258
    [Abstract] [Full Text] [Related]

  • 8. The action of neuroleptics in rats with altered catecholamine metabolism. I. The influence of MAO inhibitors on the behavioral actions of chlorpromazine, haloperidol, and thioridazine.
    Vetulani J.
    Pol J Pharmacol Pharm; 1973 Jul 23; 25(1):41-52. PubMed ID: 4798098
    [No Abstract] [Full Text] [Related]

  • 9. Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivity.
    Carvey PM, Kao LC, Zhang TJ, Amdur RL, Lin DH, Singh R, Klawans HL.
    Pharmacol Biochem Behav; 1990 Feb 23; 35(2):291-300. PubMed ID: 2320636
    [Abstract] [Full Text] [Related]

  • 10. Chronic administration of three neuroleptics: effects of behavioral supersensitivity mediated by two different brain regions in the rat.
    Halperin R, Guerin JJ, Davis KL.
    Life Sci; 1983 Aug 08; 33(6):585-92. PubMed ID: 6684202
    [Abstract] [Full Text] [Related]

  • 11. Chronic treatments with zotepine, thioridazine, and haloperidol affect apomorphine-elicited stereotypic behavior and striatal 3H-spiroperidol binding sites in the rat.
    Lai H, Carino MA, Horita A.
    Psychopharmacology (Berl); 1981 Aug 08; 75(4):388-90. PubMed ID: 6122233
    [Abstract] [Full Text] [Related]

  • 12. Behavioural effects of chronic treatment with apomorphine in combination with neuroleptic drugs.
    Kenny M, Leonard BE.
    J Neurosci Res; 1980 Aug 08; 5(4):291-8. PubMed ID: 6107385
    [Abstract] [Full Text] [Related]

  • 13. Vitamin E attenuates the development of haloperidol-induced dopaminergic hypersensitivity in rats: possible implications for tardive dyskinesia.
    Gattaz WF, Emrich A, Behrens S.
    J Neural Transm Gen Sect; 1993 Aug 08; 92(2-3):197-201. PubMed ID: 8369109
    [Abstract] [Full Text] [Related]

  • 14. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
    Smith RC, Davis JM.
    Psychopharmacol Commun; 1975 Aug 08; 1(3):285-93. PubMed ID: 1241453
    [Abstract] [Full Text] [Related]

  • 15. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
    Montanaro N, Dall'Olio R, Gandolfi O, Vaccheri A.
    Eur J Pharmacol; 1982 Jun 16; 81(1):1-9. PubMed ID: 6889533
    [Abstract] [Full Text] [Related]

  • 16. The effects of haloperidol and thioridazine on apomorphine- and LSD-induced hyperthermia in the rabbit.
    Roszell DK, Horita A.
    J Psychiatr Res; 1975 Aug 16; 12(2):117-23. PubMed ID: 1171973
    [No Abstract] [Full Text] [Related]

  • 17. Diltiazem or verapamil prevents haloperidol-induced apomorphine supersensitivity in mice.
    Grebb JA, Shelton RC, Freed WJ.
    J Neural Transm; 1987 Aug 16; 68(3-4):241-55. PubMed ID: 3559539
    [Abstract] [Full Text] [Related]

  • 18. Behavioral evidence for dopamine receptor subsensitivity following chronic haloperidol.
    Lynch MR.
    Neuropsychobiology; 1987 Aug 16; 24(2):102-8. PubMed ID: 2151972
    [Abstract] [Full Text] [Related]

  • 19. Scopolamine modulates apomorphine-induced behavior in rats treated with haloperidol or SCH 23390.
    Butkerait P, Friedman E.
    Eur J Pharmacol; 1988 Mar 29; 148(2):269-72. PubMed ID: 2897925
    [Abstract] [Full Text] [Related]

  • 20. Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy.
    Tschanz JT, Rebec GV.
    Pharmacol Biochem Behav; 1988 Nov 29; 31(3):519-22. PubMed ID: 3251235
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.